Search

everythinglearnresearchcommunity

for

Search:↓

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

PLD is an effective and safer alternative for treating breast cancer.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Cancer prevention has advanced significantly, with some strategies proving successful.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

Photoacoustic imaging can detect prostate brachytherapy seeds better with enhanced contrast methods, but depth limits remain.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.